Mounting evidence shows that HCC patients with high KMT1C expression and high levels of H3K9 di-methylation have worse survival outcomes due to KMT1C-dependent regulation of cell proliferation, angiogenesis, and anchorage of independent growth [60–64]. Here, EHMT2 is linked to hepatocellular carcinoma.